chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 196 patients received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant medications were reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient received additional booster dose. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant follow up received contains updated age group and case narrative.
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up received contains age group added and  narrative updated.
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant follow up-(Case narrative received)
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up received contains age group added and narrative updated.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 53.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 23.0
Sex: F
Vaccine: FLUC4
Symptoms: Fatigue, Flushing, Hyperhidrosis, Injection site pain, Insomnia
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Unable to Sleep-Medium
Age: 23.0
Sex: F
Vaccine: FLUC4
Symptoms: Lethargy, Pain, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Unable to Sleep-Medium
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Chest discomfort, Chest pain, Chills, Dizziness, Hypertension
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Severe, Systemic: Hypertension-Severe, Systemic: Hyperventilation-Severe, Systemic: Nausea-Severe, Systemic: Tachycardia-Severe, Systemic: Vomiting-Severe
Age: 70.0
Sex: M
Vaccine: FLU4
Symptoms: Hyperventilation, Nausea, Pyrexia, Tachycardia, Vomiting
Clinical narrative: Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fever-Severe, Systemic: Hypertension-Severe, Systemic: Hyperventilation-Severe, Systemic: Nausea-Severe, Systemic: Tachycardia-Severe, Systemic: Vomiting-Severe
Age: 71.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site bruising, Injection site erythema, Rash
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: redness 2 in diameter below injection site appeared 3 days after injection-Mild
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Stroke
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 5/15/21, 8/6/21. Positive on 12/30/22
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 3/22/21, 4/12/21. Positive on 12/31/22
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arrhythmia, Hypoaesthesia, Ventricular tachycardia
Clinical narrative: Half-body numbness on right side, lasted 12 hours with residual numbness thereafter. ER visit which referred me to my primary care facility. Heart dysrhythmia/V-tach episodes on daily basis.
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Nausea
Clinical narrative: Employee began to feel nauseous 8 minutes after injection. Nausea resolved 28 minutes after injection without treatment.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, CSF protein, Intervertebral disc degeneration, Magnetic resonance imaging spinal abnormal, Neck pain
Clinical narrative: By the middle of April 2021, I developed mild bilateral forelimb neuropathy primarily in my hands and toes slowly extending over the next two months to include my arms and thighs and lower half of my feet. I started to have difficulty neck and lower back pain.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Spinal cord operation
Clinical narrative: By the middle of April 2021, I developed mild bilateral forelimb neuropathy primarily in my hands and toes slowly extending over the next two months to include my arms and thighs and lower half of my feet. I started to have difficulty neck and lower back pain.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Poor quality product administered
Clinical narrative: Patient was given a dose from a vial that was initially punctured 29 hours prior. Per Moderna, the dose is valid.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Patient was given a dose from a vial that was initially punctured 29 hours prior. Per Moderna, the dose is valid.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Poor quality product administered
Clinical narrative: Patient was given a dose from a vial that was initially punctured 29 hours prior. Per Moderna, the dose is valid.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory abnormal, Heart rate irregular, Palpitations, Ventricular extrasystoles
Clinical narrative: Heart Pounding.  Irregular heartbeat.  Holter monitor showed 34% PVC's.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea
Clinical narrative: Patient came to the ED with complaints of shortness of breath requiring the use of oxygen via nasal cannula.  Patient admitted for Covid pneumonia and treated with remdesivir.
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: The patient did not actually have an adverse event.  She received two bivalent boosters 3 months apart.  She received the first bivalent booster of moderna on 9/21 just as we were transitioning from the old booster to the new bivalent and she didn't realize it.  She saw on tv there was a new booster in December so she came in to get it and told us she needed the new booster.  Her card date said 9/21/22 so she was due for the new booster but we didn't realize she'd already received the bivalent.  The patient hasn't had any issues so far.  The doctor has been notified, and we spoke to the patient to let her know not to get anymore boosters until guidelines change or there is a different one available.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute respiratory failure, COVID-19
Clinical narrative: Patient presented with acute hypoxic respiratory failure secondary to COVID-19
Age: 95.0
Sex: F
Vaccine: UNK
Symptoms: General symptom
Clinical narrative: Symptoms started on 1/1/23. Treatment plan includes admission and PT/OT.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Iridocyclitis
Clinical narrative: Anterior Uveitis. started roughly 2 months after COVID booster shot. first time I ever had it. no history of COVID infection at the time.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder, Cardiac stress test, Catheterisation cardiac, Computerised tomogram thorax, Dyspnoea
Clinical narrative: 1 month after the booster I woke up and could not breathe. I had several scans and eventually had to have a stent implanted and was placed on oxygen and several new medicines which I never needed prior to this booster. I was prescribed several new medicines afterward as follows: Bumex 0.5-1.0 mg, Montelukast 10 mg, Carvedilol 3.124 mg, Entrtesto 49/51 mg, Plavix 75 mg, Jardiance 10 mg
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Pulmonary function test, Scan abnormal, Scan with contrast, Stent placement
Clinical narrative: 1 month after the booster I woke up and could not breathe. I had several scans and eventually had to have a stent implanted and was placed on oxygen and several new medicines which I never needed prior to this booster. I was prescribed several new medicines afterward as follows: Bumex 0.5-1.0 mg, Montelukast 10 mg, Carvedilol 3.124 mg, Entrtesto 49/51 mg, Plavix 75 mg, Jardiance 10 mg
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Ear discomfort, Magnetic resonance imaging head, Tinnitus
Clinical narrative: Symptoms - Fullness in Ear, Tinnitus
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site rash, Injection site scab, Rash erythematous, Rash pruritic
Clinical narrative: Fluzone High-Dose Quad Injection; Red, bumpy, itchy rash 3" irregular around injection site.  Lasted approximately 1 week.  Scabbed over in approximately 1 week.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Brain neoplasm malignant, Cervix carcinoma stage IV, Death, Formication
Clinical narrative: something crawling inside her body abdominal pain which lead to cervical  and brain cancer stage 4
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Haemoglobin, Palpitations, Thyroid function test, Tremor
Clinical narrative: Heart palpitations, shortness of breath, hand tremors
Age: 48.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Burning sensation, Immediate post-injection reaction, Pain, Paraesthesia
Clinical narrative: Injection was placed in left arm. At time of injection, arm started to feel tingly. Felt as if fluid was injected interarticular. Pain started by later that evening. Joint pain started the following day. Joint pain continued and then finally notified provider. Joint pain and burning has continued since injection of vaccine.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site nodule, Injection site pain
Clinical narrative: patient has a knot on her arm and redness about 1.5 inches out around her injection site , as well as, soreness I told patient to use cold compresses for about 15 minutes at a time , and to take benadryl and ibuprofen
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Gait disturbance, Rash
Clinical narrative: Patient previously received all Pfizer Covid vaccines.  She received Moderna Bivalent and stated that several days later she had a rash that comes and goes all over her feet and legs or arms and hands.  She has been taking oral Benadryl, but the rash, according to the patient can make it difficult to walk once it appears.  She states that it can only be due to the vaccine and no other cause.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Lethargy, Pain, Pyrexia
Clinical narrative: Severe body aches and headache. Fever of 101 and lethargy.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cough, Dyspnoea, Pyrexia
Clinical narrative: Patient presents to the ED with shortness of breath, cough, fever, and generalized weakness.  Patient was admitted to the hospital with Covid and treated with remdesivir.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthropod bite, Blister, Burning sensation, Gait disturbance, Herpes zoster
Clinical narrative: Noticed bug bite on Monday by Wednesday  a rash/blisters had spread all up leg.  Went to doctor Thursday...diagnosed with shingles. Doctor prescribed Advil 3x day and  starting 9/22/22 Valacyclovir  for 7 days. Shooting pain, charley horse pains,  burning while frequently urinating  (whole left leg and crotch area rash/blisters and pain). Barely able to walk. Rash lasted approx. 3 weeks, pain lasted approx. 10 weeks, still tender skin at 15 weeks.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Muscle spasms, Pain, Pain of skin, Pollakiuria, Rash
Clinical narrative: Noticed bug bite on Monday by Wednesday  a rash/blisters had spread all up leg.  Went to doctor Thursday...diagnosed with shingles. Doctor prescribed Advil 3x day and  starting 9/22/22 Valacyclovir  for 7 days. Shooting pain, charley horse pains,  burning while frequently urinating  (whole left leg and crotch area rash/blisters and pain). Barely able to walk. Rash lasted approx. 3 weeks, pain lasted approx. 10 weeks, still tender skin at 15 weeks.
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bacterial test, Culture, Otitis media acute
Clinical narrative: acute otitis media
Age: 38.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Biopsy bone marrow abnormal, Blast cells present, Fibrosis, Thrombocytopenia
Clinical narrative: Patient received 4th dose (2nd booster) and within less than 1 month developed severe and refractory thrombocytopenia requiring hospitalization. Also noted to have a bone marrow biopsy that is concerning for ACUTE LEUKEMIA
Age: 38.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Acute leukaemia, SARS-CoV-2 test, Thrombocytopenia
Clinical narrative: Patient received 4th dose (2nd booster) and within less than 1 month developed severe and refractory thrombocytopenia requiring hospitalization. Also noted to have a bone marrow biopsy that is concerning for ACUTE LEUKEMIA
Age: 39.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 7.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 42.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 60.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 9.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered to patient
Age: 18.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Fall, Head injury, Loss of consciousness, Wound, Wound haemorrhage
Clinical narrative: Patient was standing against the wall. She leaned her head back and hit her head on the wall, at which point she dropped her phone. The patient then proceeded to bend down and pick up the phone when she passed out and hit her head on the door hinge. The pharmacist was immediately called into the immunization room and the patient's mother helped the patient sit up. After approximately 1 minute, the patient was helped up and sat down on the bench. The pharmacist checked on the patient and offered her a bottle of water. Although the patient was bleeding from a cut on her head, the patient and her mother refused ambulatory services and were given the room. The pharmacist periodically checked in on the patient and after approximately 10 minutes, the patient and her mother left the facility.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 4/22/21 Lot# 002C21A;  Moderna 05/20/21 Lot# 002C21A;  Moderna 11/13/21 Lot# 091D21A
Age: 29.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Aphthous ulcer, Glossitis, Influenza virus test negative, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: Swelling of R side of tongue beginning 8 hours post vaccine administration (Heplisav-B, seasonal influenza).  Sxs started at the front tip of tongue around 5pm on 12/28 and progressed to entire R side of tongue today (12/29).  Upon evaluation at employee health, R side of tongue looks red, irritated, swollen with some canker sore like areas.  No swelling in throat noted.
Age: 29.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Swollen tongue, Tongue erythema
Clinical narrative: Swelling of R side of tongue beginning 8 hours post vaccine administration (Heplisav-B, seasonal influenza).  Sxs started at the front tip of tongue around 5pm on 12/28 and progressed to entire R side of tongue today (12/29).  Upon evaluation at employee health, R side of tongue looks red, irritated, swollen with some canker sore like areas.  No swelling in throat noted.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after one dose Janssen vaccine
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case after 4 vaccines  Moderna 3/3/21 Lot# 030A21A;  Moderna 4/3/21 Lot# 031B21A;  Moderna 12/10/21 Lot# 013F21A; Pfizer 8/1/22 Lot# FP7139
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Lichen planus, Skin ulcer
Clinical narrative: Dermatological ulceration  Lichen Planus  -arm, mouth and genital parts.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines 1/25/21 Moderna Lot# 029L20A;  Moderna 2/25/21 Lot# 010A21A;  Moderna 10/21/21 Lot# 076C21A;  MOderna 4/8/22 Lot# 066K21A;  Pfizer 9/27/22 Lot# GH9703
Age: 34.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 40.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 64.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 65.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/12/22 Lot# 083J21A;  Moderna 3/19/22 Lot# 066K21A
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 85.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three vaccines Moderna 4/2/21 Lot# 047A21A;  Moderna 4/30/21 Lot# 017B21A;  Moderna 12/21/21 Lot# 032H21A
Age: 61.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Moderna 1/5/21 LOt# 026L20A;  Moderna 2/1/21 Lot# 007M20A
Age: 32.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Deafness unilateral, Ear discomfort, Pain, Paraesthesia
Clinical narrative: Hearing loss in right ear for two days, feeling was like like water in ear (which there was not). Also had pain all over body for several hours, plus and major tingling in left arm and hand.
Age: 69.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Moderna 1/12/21 Lot# 012L20A;  Moderna 2/9/21 Lot# 004M20A;  MOderna 12/15/21 Lot# 060H21A;  MOderna 12/15/22 Lot# 024H22A
Age: 68.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 19.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was administer bivalent dose in error.   He still needs to complete the primary series.
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received Pfizer bivalent covid booster instead of Pfizer primary monovalent 1st dose vaccine.  Both of which are maroon vials.  No known adverse effects reported by patients' parent.
Age: 53.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 32.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/1/21 Lot# 031M20A;  Moderna 3/13/21 Lot# 045A21A;  Moderna 11/1/21 Lot# 039F21A;  Pfizer 10/24/22 Lot # GJ3277
Age: 51.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 9.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 10.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 7.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 8.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 12.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 75.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 70.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Balance disorder, Dizziness, Gait disturbance, Hypoaesthesia, Laboratory test
Clinical narrative: numbness in arms and legs   tingling in fingers   too dizzy to walk without aid   very unsteady
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Paraesthesia
Clinical narrative: numbness in arms and legs   tingling in fingers   too dizzy to walk without aid   very unsteady
Age: 13.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 24.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial thrombosis, Haemorrhage, Pulmonary thrombosis, Thrombosis
Clinical narrative: Blood clots in both legs, both lower lungs, and the atria of the heart
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Transfusion
Clinical narrative: Blood clots in both legs, both lower lungs, and the atria of the heart
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Extreme swollen face from neck up.  On a road trip at the time, stopped at urgent care where I received a steroid shot.  Occurred again 3 days later, recited another steroid shot at another urgent care. Occurred 4 days later where I saw my now retired dermatologist, Dr. PRIVATE who gave me another steroid shot.
Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Magnetic resonance imaging, Mobility decreased, Pain, Periarthritis
Clinical narrative: Pain started right after. Never got better.  Developed Frozen shoulder capsulitis.  Did physical therapy, cortisone injection and now having surgery on 1/12/23.  Been sore for over a year with limited mobility.
Age: 60.0
Sex: F
Vaccine: FLU4
Symptoms: Scan with contrast
Clinical narrative: Pain started right after. Never got better.  Developed Frozen shoulder capsulitis.  Did physical therapy, cortisone injection and now having surgery on 1/12/23.  Been sore for over a year with limited mobility.
Age: 29.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 11.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 59.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 62.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 6.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 71.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Malaise, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Staff member reports not feeling well fever
Age: 51.0
Sex: F
Vaccine: HEPA, PNC20
Symptoms: Axillary pain, Chest discomfort, Musculoskeletal chest pain
Clinical narrative: PATIENT REPORTS  INTERMITTENT LOWER LEFT UNDERARM/RIB PAIN  AND TIGHTNESS OF CHEST (SHORT DURATION)
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anaphylactic reaction, Syncope
Clinical narrative: upon receiving the updated bivalent pfizer covid 19 vaccine, the patient fainted and began to display signs and symptoms of anaphylaxis. she was there with her parents, and was helped to the floor so she was not injured from a fall. A technician yelled for the pharmacist on duty who administered epinephrine while 911 was called. the pharmacist stayed with patient monitoring symptoms until an ambulance arrived. She was taken to the emergency room where she was treated for anaphylaxis. the pharmacist followed up the next day with the family when she picked up her er prescriptions and had appeared to have made a full recovery.
Age: 92.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Heart rate increased, Hypertension, Palpitations, Rash
Clinical narrative: Palpitation through out the body, increased heart beat, rash on her face  Given Diphenhydramine 25 mg.  Checked blood pressure and it was high 148, and 160 then went down to 128.  Patient said she did not feel palpitation anymore after 10-15 min.   Patient was told to monitor blood pressure at home and would feel drowsy due to allergy medication.  She was sent to home with her son.
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pt was given bivalent covid for first covid immunization. No adverse events known at this time.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Echocardiogram, Exercise tolerance decreased, Fatigue
Clinical narrative: High heart rate, hands turned purple, high fever, dizziness,chills, body aches, orthostatic intolerance. All within 1 day of dose. Diagnosed with POTS thereafter. Medications have helped tachycardia but continue to have brain fog, fatigue, exercise intolerance, heat/humidity intolerance.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate increased, Humidity intolerance, Orthostatic intolerance, Pain
Clinical narrative: High heart rate, hands turned purple, high fever, dizziness,chills, body aches, orthostatic intolerance. All within 1 day of dose. Diagnosed with POTS thereafter. Medications have helped tachycardia but continue to have brain fog, fatigue, exercise intolerance, heat/humidity intolerance.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Postural orthostatic tachycardia syndrome, Pyrexia, Skin discolouration, Tachycardia, Temperature intolerance
Clinical narrative: High heart rate, hands turned purple, high fever, dizziness,chills, body aches, orthostatic intolerance. All within 1 day of dose. Diagnosed with POTS thereafter. Medications have helped tachycardia but continue to have brain fog, fatigue, exercise intolerance, heat/humidity intolerance.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Tilt table test
Clinical narrative: High heart rate, hands turned purple, high fever, dizziness,chills, body aches, orthostatic intolerance. All within 1 day of dose. Diagnosed with POTS thereafter. Medications have helped tachycardia but continue to have brain fog, fatigue, exercise intolerance, heat/humidity intolerance.
Age: 12.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: patient was given bivalent dose when they were expecting first dose in the series.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was vaccinated beyond use date of 5/6/2022. No symptoms reported by patient.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: Occasional extremely high blood pressure (as high as 240/100)
Age: 26.0
Sex: F
Vaccine: FLUC4
Symptoms: Circumstance or information capable of leading to medication error, Incorrect product formulation administered, Product packaging confusion
Clinical narrative: Client came by to receive the Bivalent booster made by Moderna. They received the monovalent booster in error. The client has been notified, waiting on call back to consult.Contributing factors include high volume, similarities between the two packages, improper workflow by the pharmacist, and storage of the two similar medications directly next to each other.
Age: 72.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue, Underdose
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 19.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 75.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 21.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 32.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 68.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 63.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 16.0
Sex: F
Vaccine: COVID19-2, COVID19-2, UNK
Symptoms: Underdose
Clinical narrative: Vaccine administration error: Wrong product selected for age. Patient was in with her younger sister for their Pfizer Bivalent COVID-19 vaccinations. The nurse (RN who is also their grandmother) selected the 10mcg/0.2 mL Pfizer Bivalent COVID-19 formulation (for 5-11 yr olds) and administered it to the 16 yr old granddaughter instead of the 10 year old granddaughter. The 10 mcg/0.2 mL dose was given in the Left Deltoid and the error was immediately recognized. The nurse reported the error to her supervisor (RN) and the supervising physician (DO). The local DOH was called and a voicemail left regarding the error and documentation. Based on the CDC guidance to complete the dose, a
Age: 18.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Incorrect product formulation administered
Clinical narrative: Client and family came by to receive the Bi-valent booster made by Moderna. They received the mono-valent booster in error. The family has been notified, and advised about potential adverse reactions such as a sore arm in the morning. The family was also advised to wait 2 months before getting the bivalent booster in accordance with current recommendations. The family members seemed frustrated, but understanding and appreciative of the pharmacy?s openness with them regarding the situation. Contributing factors include high volume, similarities between the two packages, improper workflow by the pharmacist, and storage of the two similar medications directly next to each other.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue, Underdose
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Itching and hives over entire body, mainly torso and legs
Age: 67.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue, Underdose
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 14.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Immediate post-injection reaction, Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: I got a shot in my left arm. There was immediate pain in my arm. This was the most painful shot(by far) that I've ever had. My left arm became pretty much useless, I couldn't lift it above waist level without pain. I went to a doctor when after a month the pain was still there and not getting any better. The Doctor had no idea what was the problem. I had x-rays, but they found nothing. The Doctor after two months gave me a cortisone shot. This did nothing for me. After about 6 months, the pain finally went away. I was told that you could get that kind of reaction if the shot is given to high on the shoulder, I accepted that. When I got my next booster, I got it in my right arm. After about 3 days, I started feeling pain in my right shoulder and still do.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: X-ray normal
Clinical narrative: I got a shot in my left arm. There was immediate pain in my arm. This was the most painful shot(by far) that I've ever had. My left arm became pretty much useless, I couldn't lift it above waist level without pain. I went to a doctor when after a month the pain was still there and not getting any better. The Doctor had no idea what was the problem. I had x-rays, but they found nothing. The Doctor after two months gave me a cortisone shot. This did nothing for me. After about 6 months, the pain finally went away. I was told that you could get that kind of reaction if the shot is given to high on the shoulder, I accepted that. When I got my next booster, I got it in my right arm. After about 3 days, I started feeling pain in my right shoulder and still do.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue, Underdose
Clinical narrative: Patient was administered vaccine that was found to be over diluted on reconstitution.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Client and family came by to receive the Bi-valent booster made by Moderna. They received the mono-valent booster in error. The family has been notified, and advised about potential adverse reactions such as a sore arm in the morning. The family was also advised to wait 2 months before getting the bivalent booster in accordance with current recommendations. The family members seemed frustrated, but understanding and appreciative of the pharmacy?s openness with them regarding the situation. Contributing factors include high volume, similarities between the two packages, improper workflow by the pharmacist, and storage of the two similar medications directly next to each other.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient
Age: 56.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was frozen rather than refrigerated. patient was given dose. no symptoms reported. revaccination offered to patient